Favorable Humoral Response to Third Dose of BNT162b2 in Patients Undergoing Hemodialysis

Patients undergoing hemodialysis are known to exhibit low humoral responses to vaccines against severe acute respiratory syndrome coronavirus 2. In this study, we aimed to elucidate the humoral response to the third dose of BNT162b2 (Pfizer) in patients undergoing hemodialysis. We included 279 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitamura, Mineaki, Takazono, Takahiro, Yamaguchi, Kosei, Tomura, Hideshi, Yamamoto, Kazuko, Harada, Takashi, Funakoshi, Satoshi, Mukae, Hiroshi, Nishino, Tomoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024432/
https://www.ncbi.nlm.nih.gov/pubmed/35456182
http://dx.doi.org/10.3390/jcm11082090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024432/
https://www.ncbi.nlm.nih.gov/pubmed/35456182
http://dx.doi.org/10.3390/jcm11082090

Ejemplares similares